Rockville, MD – Recently, the U.S. Food and Drug Administration (FDA) green-lighted over-the-counter NAUS-EASE® (Meclizine HCl) 25mg tablets for use as an antiemetic – to prevent and treat nausea and vomiting. NAUS-EASE® (Meclizine HCl) tablets are currently the only prescription quality drug available over the counter for the prevention and treatment of nausea and vomiting, with up to 24 hour relief from a single dose. This marks a key step in providing individuals who suffer from infrequent nausea and vomiting, access to a superior quality over the counter product that is trusted by doctors, pharmacists, and patients.
When it comes to over the counter medications and healthcare products, it is evident that consumers want to purchase a product for its quality and effectiveness, not just the manufacturing facility it comes from. Sunascen Therapeutics has been committed to developing and promoting superior quality products designed to improve and protect the consumer’s health. The addition of non-prescription NAUS-EASE® to the Sunascen Therapeutics product portfolio also marks the beginning of an expansive number of developing products and categories. “We want to assist consumers in managing their health needs by enabling them to select our products with confidence to meet those needs. Our goal is to develop products which exceed FDA requirements with a level of quality that remains unsurpassed by its competitors, especially for over the counter medications,” said Dr. Sandip Patel, Chief Executive Officer of Sunascen Therapeutics LLC.
We will continue to work closely with our retail partners to make NAUS-EASE® tablets available to consumers throughout the United States by year-end 2014.
For more information on NAUS-EASE®, please visit www.NAUSEASE.com
About Sunascen Therapeutics LLC
At Sunascen Therapeutics, we apply extensively researched science and our technical resources to develop pharmaceutical and healthcare products, which are designed to ease suffering and enhance the quality of life. Consistent with our corporate strategy, corporate responsibility, and our consumer’s expectations, we value the discovery and development of quality healthcare products, diagnostic tools, and medical devices, both prescription and OTC. We aim to surpass the current standard for quality, safety and effectiveness.
Along with the advisory and management consulting services offered, Sunascen Therapeutics is continuously strengthening the product portfolio by searching for business partners interested in co-developing new pharmaceutical products that fit within, and complement our corporate and product development strategy. We develop strategic partnerships with existing, and emerging companies to develop and commercialize safe, effective, and innovative treatments for diseases which have insufficient treatment options or medical needs that remain unmet, including those of orphan diseases. We offer a full range of product development and support services designed to accelerate innovation and efficiently execute the approval process, new market entry, and support. Our entire production, operations, and corporate governance are based in the United States of America.
For more information on Sunascen Therapeutics LLC, please visit www.SUNASCEN.com
Corporate Contact:
Dr. Sandip Patel
Chief Executive Officer
Sunascen Therapeutics LLC
(240) 403-2614
info@sunascen.com
Help employers find you! Check out all the jobs and post your resume.
When it comes to over the counter medications and healthcare products, it is evident that consumers want to purchase a product for its quality and effectiveness, not just the manufacturing facility it comes from. Sunascen Therapeutics has been committed to developing and promoting superior quality products designed to improve and protect the consumer’s health. The addition of non-prescription NAUS-EASE® to the Sunascen Therapeutics product portfolio also marks the beginning of an expansive number of developing products and categories. “We want to assist consumers in managing their health needs by enabling them to select our products with confidence to meet those needs. Our goal is to develop products which exceed FDA requirements with a level of quality that remains unsurpassed by its competitors, especially for over the counter medications,” said Dr. Sandip Patel, Chief Executive Officer of Sunascen Therapeutics LLC.
We will continue to work closely with our retail partners to make NAUS-EASE® tablets available to consumers throughout the United States by year-end 2014.
For more information on NAUS-EASE®, please visit www.NAUSEASE.com
About Sunascen Therapeutics LLC
At Sunascen Therapeutics, we apply extensively researched science and our technical resources to develop pharmaceutical and healthcare products, which are designed to ease suffering and enhance the quality of life. Consistent with our corporate strategy, corporate responsibility, and our consumer’s expectations, we value the discovery and development of quality healthcare products, diagnostic tools, and medical devices, both prescription and OTC. We aim to surpass the current standard for quality, safety and effectiveness.
Along with the advisory and management consulting services offered, Sunascen Therapeutics is continuously strengthening the product portfolio by searching for business partners interested in co-developing new pharmaceutical products that fit within, and complement our corporate and product development strategy. We develop strategic partnerships with existing, and emerging companies to develop and commercialize safe, effective, and innovative treatments for diseases which have insufficient treatment options or medical needs that remain unmet, including those of orphan diseases. We offer a full range of product development and support services designed to accelerate innovation and efficiently execute the approval process, new market entry, and support. Our entire production, operations, and corporate governance are based in the United States of America.
For more information on Sunascen Therapeutics LLC, please visit www.SUNASCEN.com
Corporate Contact:
Dr. Sandip Patel
Chief Executive Officer
Sunascen Therapeutics LLC
(240) 403-2614
info@sunascen.com
Help employers find you! Check out all the jobs and post your resume.
